|   HOME   |   SITEMAP   |   CONTACT    
About us
      Advisory Board I
      Advisory Board II
Breslin AG
Breslin Biotech AG


Dr. David Karabelnik
CEO, Private Equity/Life Sciences

• 12 Years of International VC and PE Experience
• Breslin Biotech: Building of BdW-Dresdner-Allianz Life Sciences Portfolio
• Life Sciences Advisor to Commerzbank and Deutsche Bank
• VC&Biotech S.Francisco
• 12 years Biotech Entrepreneur at ANAWA (Founder and Managing Director)
• Ph.D. and Masters in Biochemistry (ETH Zurich)

Malcolm Williams
Private Equity

• 38 Years of Private Equity Experience at Dresdner Kleinwort Wasserstein
• COO of Dresdner-Allianz Private Equity Group (>Euro 4bn under Mgmt of Direct and
   Fund Investm.)
• CEO of Kleinwort Benson Limited, Hong Kong
• Member of the Mgmt Board of Kleinwort Benson, Germany

Klaus Berding
Life Sciences/Private Equity

• 4 Years as Management Consultant in Life Sciences
• 7 Years VP Corporate Finance at Dresdner Kleinwort Wasserstein
• 6 Years as Senior Analyst in Sell-Side Research at Dresdner Bank AG
• Diploma and Seminars: DVFA Investmentanalyst, Venture Capital (EVCA),
   Business Development
• MBA (University Bochum)

Dr. Martin Schnee
Industrial- and Clean-Tech/Life Sciences

• 7 Years Independent Analyst Chemistry ,Life Sciences
• 1 Year Sector Analyst with Euroratings AG
• 2 Years Sector Analyst in Sell-Side with Independent Research
• Certified Biotech Analyst and Certified Credit Analyst (DVFA) PhD in Chemistry
   (Frankfurt University)

Fanina Karabelnik
Back Office/Admin

Graduation in Business  Administration at University of St.Gallen (HSG) in 2010
• 3 years Work Experience and Internships in  Various Companies in the area
  of Pharma/Biotech, Private Equity, Start-up, Fashion/Entertainment and Marketing

© Breslin AG; webdesign by firegroup